Canada markets open in 4 hours 50 minutes

Canntab Therapeutics Limited (TBF1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.4820-0.0140 (-2.82%)
As of 8:03AM CET. Market open.
Full screen
Previous Close0.4960
Open0.4820
Bid0.4820 x 0
Ask0.5100 x 0
Day's Range0.4820 - 0.4820
52 Week Range0.1590 - 0.7150
Volume3,000
Avg. Volume79
Market Cap16.633M
Beta (5Y Monthly)1.25
PE Ratio (TTM)N/A
EPS (TTM)-0.0870
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Canntab Announces Closing of Convertible Debenture Private Placement
    Newsfile

    Canntab Announces Closing of Convertible Debenture Private Placement

    Toronto, Ontario--(Newsfile Corp. - December 31, 2020) - Canntab Therapeutics Limited. (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) ("Canntab" or the "Company"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the closing of a non-brokered private placement (the "Offering") of secured convertible debentures of the Company ("Convertible Debentures"), pursuant to which the Company issued Convertible Debentures for gross proceeds of $1,575,000 (the "Convertible Debentures"). The ...

  • CNW Group

    COVID-19 Pandemic - The government presents its daily update

    QUÉBEC CITY, Nov. 28, 2020 /CNW Telbec/ - The most recent data on the evolution of COVID-19 in Québec show 1,480 new cases, bringing the total number of people infected to 139,643.

  • Canntab Therapeutics Announces End of Supply and Distribution Agreements with Exactus
    Newsfile

    Canntab Therapeutics Announces End of Supply and Distribution Agreements with Exactus

    Toronto, Ontario--(Newsfile Corp. - November 16, 2020) -  Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announces that Canntab and Exactus, Inc. have mutually agreed to terminate the supply and distribution agreements previously announced on November 20, 2019, after determining that the regulatory requirements could not be completed on a timely basis.During a time ...